ClinicalTrials.gg
Sign In
CompletedNCT03295123DENIGROUpdated Feb 15, 2023

Outcome of Children Born After Pregnancy Denial

An observational study in Child Development, Denial (Psychology) and Disease, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 1 Day to 8 Years. Per ClinicalTrials.gov, last updated 2023-02-15.

Primary conditionnone(registry's first term: Disease)No conditionIs this wrong?Disease describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Central Hospital, Nancy, France · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
41
Ages
1 Day to 8 Years
Sex
All
01

Study summary

The objective of this study is to evaluate the impact of denial pregnancy on children's health ( anthropometric data, psychomotor development , disease) at different age of evaluation ( at birth, 9 months, 24 months and between 2 and 6 years post natal age).

The hypothesis is the denial of pregnancy may have repercussions on children's outcome.

02

Conditions studied

  • Child Development
  • Denial (Psychology)
  • Disease
  • Personality Development

Browse trials for

03

In context

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.

Browse Central Hospital, Nancy, France studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 8 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Every children born at term after denial of pregnancy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child born after denial of pregnancy
  • Child born at term ( > 37 weeks of gestation)
  • Born between the 1st january 2009 and the 30th june 2015 at Maternité Regionale de Nancy

Exclusion criteria

Exclusion Criteria:

  • Mother's opposition
  • Child doesn't' living in France
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
41 participants (actual)
Patient registry
No

Interventions

  • Otherphone interview with the mother

    it's a telephone survey about children's health

06

What researchers measure

Primary outcomes

  1. height (cm)

    infants height will be recorded from their health booklet and compared to reference chart log

    Time frame: birth

  2. height (cm)

    infants height will be recorded from their health booklet and compared to reference chart log

    Time frame: 9 months

  3. height (cm)

    infants height will be recorded from their health booklet and compared to reference chart log

    Time frame: 24 months

  4. height (cm)

    infants height will be recorded from their health booklet and compared to reference chart log

    Time frame: between 2 and 5 years

  5. weight (kg)

    infants weight will be recorded from their health booklet and compared to reference chart log

    Time frame: birth

  6. weight (kg)

    infants weight will be recorded from their health booklet and compared to reference chart log

    Time frame: 9 months

  7. weight (kg)

    infants weight will be recorded from their health booklet and compared to reference chart log

    Time frame: 24 months

  8. weight (kg)

    infants weight will be recorded from their health booklet and compared to reference chart log

    Time frame: between 2 and 5 years

Secondary outcomes

  1. psychomotor development

    infants psychomotor development items will be recorded from their health booklet and compared to reference chart log

    Time frame: birth

  2. psychomotor development

    infants psychomotor development items will be recorded from their health booklet and compared to reference chart log

    Time frame: 9 months

  3. psychomotor development

    infants psychomotor development items will be recorded from their health booklet and compared to reference chart log

    Time frame: 24 months

  4. psychomotor development

    infants psychomotor development items will be recorded from their health booklet and compared to reference chart log

    Time frame: between 2 and 5 years

  5. disease

    all diseases which occured from birth will be recorded from their health booklet and compared to reference chart log

    Time frame: birth

  6. disease

    all diseases which occured from birth will be recorded from their health booklet and compared to reference chart log

    Time frame: 9 months

  7. disease

    all diseases which occured from birth will be recorded from their health booklet and compared to reference chart log

    Time frame: 24 months

  8. disease

    all diseases which occured from birth will be recorded from their health booklet and compared to reference chart log

    Time frame: between 2 and 5 years

07

Study locations

1 site
  • Maternity Hospital CHRU
    Nancy, 54035, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2017 to primary completion in Aug 2017, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2017
First posted
Sep 27, 2017
StartActual
May 3, 2017
Primary completionActual
Aug 1, 2017
CompletionActual
Aug 31, 2017
Last update
Feb 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03295123
Lead sponsor
Central Hospital, Nancy, France
Responsible party
Jean-Michel HASCOET (Professor, Central Hospital, Nancy, France) — Principal investigator
First posted
Sep 27, 2017
Start date
May 3, 2017
Primary completion
Aug 1, 2017
Completion
Aug 31, 2017
Last update
Feb 15, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Rejection, Psychology

Other studies from this sponsor

Central Hospital, Nancy, France →

Start the discussion